Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Sun

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Scientific Reports|September 30, 2021
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myelomaKinan Alhallak, Amanda Jeske, Pilar de la Puente, et al.
Oncotarget|September 22, 2021
Nanoparticle T cell engagers for the treatment of acute myeloid leukemiaKinan Alhallak, Jennifer Sun, Barbara Muz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2020
Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect ProfileCinzia Federico, Jennifer Sun, Barbara Muz, et al.
Acta Neuropathologica Communications|February 13, 2025
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cellsMichael Whitehead, Joshua P Harvey, Paul E Sladen, et al.
Ophthalmology. Retina|February 2, 2025
Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases: Consensus-Based RecommendationsMarion R Munk, Ferhat Turgut, Livia Faes, et al.
Cancers|February 5, 2020
Targeting CD47 as a Novel Immunotherapy for Multiple MyelomaJennifer Sun, Barbara Muz, Kinan Alhallak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaNaval Daver, James S Blachly, Armin Ghobadi, et al.
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.
Diabetologia|August 19, 2025
Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetesMarc Gregory Yu, Hetal Shah, Surya Jangolla, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|September 30, 2021
A pilot study of 3D tissue-engineered bone marrow culture as a tool to predict patient response to therapy in multiple myelomaKinan Alhallak, Amanda Jeske, Pilar de la Puente, et al.
Oncotarget|September 22, 2021
Nanoparticle T cell engagers for the treatment of acute myeloid leukemiaKinan Alhallak, Jennifer Sun, Barbara Muz, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2020
Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect ProfileCinzia Federico, Jennifer Sun, Barbara Muz, et al.
Acta Neuropathologica Communications|February 13, 2025
Disruption of mitochondrial homeostasis and permeability transition pore opening in OPA1 iPSC-derived retinal ganglion cellsMichael Whitehead, Joshua P Harvey, Paul E Sladen, et al.
Ophthalmology. Retina|February 2, 2025
Standardization of OCT Angiography Nomenclature in Retinal Vascular Diseases: Consensus-Based RecommendationsMarion R Munk, Ferhat Turgut, Livia Faes, et al.
Cancers|February 5, 2020
Targeting CD47 as a Novel Immunotherapy for Multiple MyelomaJennifer Sun, Barbara Muz, Kinan Alhallak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
Phase 1 Study of KITE-222, an Autologous CLL-1-directed CAR T-cell Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaNaval Daver, James S Blachly, Armin Ghobadi, et al.
Nature Cancer|January 6, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trialPaolo Strati, Lori Leslie, Parveen Shiraz, et al.
Leukemia & Lymphoma|May 17, 2021
3D tissue engineered plasma cultures support leukemic proliferation and induces drug resistanceKinan Alhallak, Pilar de la Puente, Amanda Jeske, et al.
Diabetologia|August 19, 2025
Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetesMarc Gregory Yu, Hetal Shah, Surya Jangolla, et al.
Pageof 7